Phosphatidylinositol 3-kinase: a novel effector.
Parker
P J
PJ
Imperial Cancer Research Fund, Lincoln's Inn Fields, London, United Kingdom.
Waterfield
M D
MD
D000818:Animals; D002455:Cell Division; D004789:Enzyme Activation; D019204:GTP-Binding Proteins / Q000378:metabolism; D006133:Growth Substances / Q000502:physiology; D008954:Models, Biological; D019869:Phosphatidylinositol 3-Kinases; D010716:Phosphatidylinositols / Q000378:metabolism; D010750:Phosphoproteins / Q000378:metabolism; D010766:Phosphorylation; D010770:Phosphotransferases / Q000235:genetics / Q000502:physiology*; D011487:Protein Conformation; D011499:Protein Processing, Post-Translational; D011956:Receptors, Cell Surface / Q000378:metabolism; D015398:Signal Transduction
D006133:Growth Substances; D010716:Phosphatidylinositols; D010750:Phosphoproteins; D011956:Receptors, Cell Surface; D010770:Phosphotransferases; D019869:Phosphatidylinositol 3-Kinases; D019204:GTP-Binding Proteins